Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence

@article{Watermeyer2018NeuroinflammationIP,
  title={Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence},
  author={Tamlyn J Watermeyer and V. Raymont and K. Ritchie},
  journal={Journal of Alzheimers Disease & Parkinsonism},
  year={2018},
  volume={8},
  pages={1-6}
}
The pathology of sporadic Alzheimer’s disease (AD) may be present at mid-life and precede the prodromal and clinical dementia syndromes associated with the disorder by decades. Few successful therapeutic treatments exist and, as a result, attention is turning to the preclinical stages of the disease for the development of future intervention strategies. The success of such strategies will rely on well-defined biomarkers of preclinical disease to identify and monitor changes earlier in the… Expand
2 Citations

References

SHOWING 1-10 OF 70 REFERENCES
Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?
  • 55
Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum?
  • A. Cuello
  • Medicine
  • Trends in pharmacological sciences
  • 2017
  • 61
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility
  • 77
A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease
  • 32
  • PDF
The clinical picture of Alzheimer's disease in the decade before diagnosis: clinical and biomarker trajectories.
  • 31
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
  • 2,417
  • PDF
Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
  • 48
  • PDF
Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
  • 18
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
  • 3,248
  • PDF
...
1
2
3
4
5
...